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The role of cardiovascular CT in occupational health assessment for coronary heart disease:
An expert consensus document from the Society of Cardiovascular Computed Tomography (SCCT)
A R T I C L E I N F O
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Preamble
In response to the increasing application of cardiovascular computed
tomography (cardiovascular CT), the Society of Cardiovascular
Computed Tomography (SCCT) guidelines committee has produced this
document to guide the use of cardiac CT in the risk assessment of coronary artery disease (CAD) in occupational health evaluation. The purpose
of this document is to support quality care given to individuals who
undergo occupational health evaluation for the diagnosis of CAD. This
document reviews evidence regarding the prevalence of coronary artery
disease (CAD), the incidence of major adverse cardiac events (MACE),
and the recommendations for enhanced cardiovascular screening and
investigation for CAD evaluation amongst safety sensitive occupations.
This document examines occupation risk categories where cardiac CT
may be appropriate to investigate for CAD and evaluates available testing
strategies for risk assessment.
1. Introduction
Cardiovascular disease (CVD) is one of the commonest causes of
incapacitation and death globally; it remains the leading cause of mortality in the United States (US) where it accounts for one in every three
deaths.1 On a global scale, CVD is the leading cause of death with an
estimated death toll of 17.9 million accounting to 31% of all-cause
mortality in 2016.2 Using the US as an example, over 130 million
adults are employed, representing 55% of the adult population. The
evaluation of CVD and cardiovascular risk factors are essential when
considering occupational health and safety. The inﬂuences of health on

work, and work on health, are well established and the impact of CVD
morbidity and mortality is estimated to account for $120 billion in lost
productivity in the workplace in the US alone.3 Unfortunately, widespread variation remains in occupational health evaluation, with limited
consensus regarding occupation and patient-speciﬁc criteria that may
warrant additional enhanced screening for CVD. One of the most signiﬁcant challenges facing CVD prevention is the “prevention paradox”;
where patients at the highest relative risk for CHD can be identiﬁed based
on risk factors, but most adverse cardiovascular events occur in patients
considered to be low- or intermediate-risk by current clinical risk scores
(Figs. 1 and 2).
2. Evidence review
The SCCT occupational working group reviewed published recommendations by cardiovascular societies and preventive task forces4,5 and
performed a comprehensive review of the literature6–9 (PubMed, Scopus,
EMBASE and Cochrane Library from their inception through March
2017) for all English-language evidence related to occupational health
evaluations for CAD in pilots, astronauts, commercial drivers, military
personnel, police ofﬁcers and ﬁreﬁghters. (see Table 1)
To standardize the terminology throughout the document, the
working group adopted the term “safety-sensitive” for occupations that
have been assessed for elevated risk to the worker, society or work
environment. This terminology was ﬁrst used by the American College of
Occupational and Environmental Medicine (ACOEM).10 Before exploring
the detail of the evidence identiﬁed in the literature search this manuscript outlines the basic concepts of occupational medicine, risk assessment and acceptable risk, which must be understood as a pre-requisite to
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combined with clinical judgment, exceeds the expected risks of the
procedure and the downstream impact of poor test performance (such as
a delay in diagnosis (false negatives), or inappropriate diagnosis (false
positives)”.12
Cardiovascular screening in safety sensitive occupations may be
divided into initial screening and enhanced screening.56 Initial screening
often includes the use of risk assessment calculators, a standard 12-lead,
or exercise, electrocardiogram, and screening bloods. Enhanced
screening may include coronary artery calcium scoring and, increasingly
coronary CT angiography (CTA). Enhanced screening is usually performed when either a positive ﬁrst line screening test identiﬁes a potential increased likelihood of occupationally signiﬁcant cardiovascular
disease or the level of risk acceptance is such that clear and unequivocal
exclusion of occupationally relevant disease is required.
The decision to pursue screening or occupational investigation should
ﬁrst and foremost be made on clinical grounds, against deﬁned risk parameters. The appropriate use of tests to detect CVD in occupational
medicine and the concept of ‘acceptable risk’ are ill-deﬁned in the
literature, and there are a lack of studies that compare the impact of risk
assessment tools on occupation health, public safety, resource utilization,
and long-term outcomes.
In those who work in safety sensitive occupations, investigations must
be requested, interpreted and acted upon with caution to avoid untoward
career impact. There is understandable anxiety provoked by occupational
health screening and investigation as test results may impact work
eligibility, and any variability of interpretation of test results among
experts may lead to regulatory and potentially legal challenges. Investigations may also lead to unexpected incidental ﬁndings, which in
themselves may provoke anxiety or detect occupationally signiﬁcant
disease processes that were not previously of concern.
In occupational health, consideration is given to the duty to protect
both the individual worker and society at large. The principle “ﬁrst, do no
harm” applies to both the worker and the potential population at risk.
Screening policies must not be overly restrictive however, as this may
have unintended secondary consequences. As an example, from an employer’s perspective, among asymptomatic aging pilots with subclinical
atherosclerosis and well controlled ASCVD risk factors, “it may be preferable to allow experienced pilots to continue to ﬂy, possibly with

Abbreviations
CAC
coronary artery calcium
CAD
coronary artery disease
CHD
coronary heart disease
Cardiac CT Cardiac computed tomography
Coronary CTA Coronary computed tomographic angiography
ICA
invasive coronary angiography
GXT
graded exercise treadmill test
SPECT
Single Photon Emission Computerized Tomography
MACE
major adverse cardiac events
critically appraising the literature on cardiovascular disease in occupational risk assessment.

3. Occupational medicine: legal/ethical considerations
It is the impact of work on health, and health on work that forms the
basis of occupational medicine.11 Published literature deﬁning occupational risk are sporadic and lack consensus, and agreement of the level of
risk that mandates increased enhanced cardiovascular screening, for
prevention of untoward outcomes (to both individuals and society), is
variable and usually determined by the employer.
This document focuses on the diagnosis of CAD in working-aged
adults and considers the evidence for commercial pilots and drivers, astronauts, military personnel, police ofﬁcers and ﬁreﬁghters all of which
are deemed “safety-sensitive” occupations. Among these professions,
health screening aims to preserve personal and public safety, as occupational environments may expose these patients to an increased risk of
major adverse cardiovascular events (MACE) or geographically limit the
individual’s access to timely healthcare.
Screening and investigation in occupational health is complex, and
guidelines of the Faculty of Occupational Medicine advise that any
screening procedures are both ethically and clinically justiﬁable. Additionally, the American College of Cardiology recommends that an
appropriate test is one in which “the expected incremental information,

Fig. 1. Challenges of CAD prevention and risk assessment in safety sensitive occupations.
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Fig. 2. Coronary artery disease in safety sensitive occupations.

4.1. Acceptable risk

restrictions on employment, rather than to replace their experience with
novice pilots, as the use of overly strict medical criteria may paradoxically increase accident rates”.13,14 The use of radiation based investigations for enhanced screening must also be considered with the risk
to the individual needing to be balanced against the requirement for
employers to ensure safety in the high-hazard employment areas.
Ethical and legal considerations also vary across occupation and between international regulatory agencies. In the US, for example, the
Genetic Information Nondiscrimination Act of 2008 limits the use of
family history and genetic tests in employment screening. This is notable
in CVD risk assessment, as a family history of early CAD is associated with
an increased risk of myocardial infarction and plaque burden in young
patients. Age is a strong predictor of CVD risk, and yet judges have ruled
that prior mandatory age retirements for pilots violate age discrimination
legislation, both in the US and Europe.
Accurate reporting of medical conditions to licensing authorities can
also be challenging, as occupation candidates are often required to selfreport their medical history. While most candidates will provide full
disclosures, the potential for recall bias and unreported (or undetected)
illness remains.15 In pilots, the International Civil Aviation Organization
(ICAO) regulations require an independent aeromedical examiner (AME)
to certify ﬁtness, with full access to medical records. However, some
countries (such as Germany) have laws that permit only a partial transfer
of information, weighing patient privacy against public safety. Signiﬁcant debate remains in this area and ongoing legal challenges continue to
weigh up the interest of public safety versus individual’s right to privacy.

All individuals who undertake any activity that requires a license may
be subject to screening against an accepted risk standard. As an example,
in the UK the acceptable annual risk for incapacitation to hold a standard
driving license, for domestic purposes is 20% per annum (pa), whilst for a
heavy goods vehicle (truck) driver it is 2% pa. In commercial aviation the
acceptable risk basis used by the Federal Aviation Authority (FAA) in the
United States, the European Aviation Safety Agency (EASA) in Europe
and the Civil Aviation Authority (CAA) for dual-crew ﬂying operations is
1% pa, with single seat commercial pilots (most often in the military)
having far more rigid standards. Commercial rules are more stringent
than those applied to those undertaking recreation ﬂying.
It can immediately be realized that the level of evidence available
against these very low risk acceptance levels is lacking in the usual
clinical literature on cardiovascular medicine and therefore a different
approach to cardiovascular risk assessment may be required to give
assurance to the employer that the organizational risk threshold is not
being exceeded.
4.2. Healthy worker effect
Many, but not all, individuals who undertake safety-sensitive activities are both screened for their level of ﬁtness at recruitment and expected to meet certain ﬁtness standards throughout their careers.
As an example, astronauts are generally regarded as a selected group
of healthy workers. By the nature of their high levels of ﬁtness and
health, they are expected to show a lower risk of cardiac events compared
with the general population (“healthy worker effect”).16,17 The healthy
worker effect is determined by both the initial selection process (hiring
more ﬁt persons) and the continuing employment of healthy persons,
who typically get annual physicals to assess levels of ﬁtness and ﬁtness
for duty.17 Evidence of a reduced mortality from CVD in safety sensitive
professionals is often quoted, but evidence in aircrew, astronauts, the
military and the emergency services all show similar prevalence rates of
disease to the general population at the same age.
In aircrew, despite a consistent ﬁnding of lower risk of CVD mortality
compared to the general population, the prevalence of CAD in pilots is
the same as age-matched controls in the general population,18,19 and

4. Fundamentals of investigating CAD in safety sensitive
occupations
Before looking at the speciﬁc investigations used to screen workers
undertaking deﬁned safety-sensitive occupations it is useful to explore
the concepts of acceptable risk (to employers, or licensing authorities);
the concept of a “healthy worker” effect; the age demographic of the
workforce (as compared to the usual age-distribution from which much
clinical evidence is gathered) and the inherent strengths and weakness of
the investigations available to clinicians to investigate CAD, against the
level of permitted risk.
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Table 1
Appropriate Use Guidelines for Cardiac CT in Safety-Sensitive Occupation Health Exams. Safety-sensitive deﬁned as occupations where sudden incapacitation or sudden death may endanger the safety of others (ex. pilots).* By ACC/AHA
Pooled Cohort Risk Calculator or equivalent. Note: GINA Act may limit use of family history for employment screening in the
US.206CAC test may be appropriate if combined with functional testing to improve the sensitivity of a negative stress test
when CAC ¼ 0. CAD, coronary artery disease; DM, diabetes mellitus; HLD, hyperlipidemia.

comparative normal population.37
The “healthy worker effect” does not apply to either ﬁreﬁghters or
commercial motor vehicle (CMV) drivers. The prevalence of cardiovascular risk factors is higher among CMV drivers relative to other occupations.38 Commercial drivers have an especially high smoking
prevalence,39–41 frequent hyperlipidemia,40–43 overweight or obesity
range body mass indices,39–43 diabetes,41 and hypertension.44–46 Multiple studies have demonstrated that ﬁreﬁghters have greater subclinical
atherosclerosis than the general population, independent of coronary risk
factors, and that traditional CVD risk assessment does not adequately
identify at-risk ﬁreﬁghters.47 Data suggests that police ofﬁcers are less
likely to die of CVD than ﬁreﬁghters while on duty48 with mixed results
when assessing whether they have increased atherosclerosis as compared
to the general population.

whilst most experienced astronauts are middle aged, and at risk for
developing major adverse cardiovascular events, recent contemporary
data has revealed similar rates of developing CVD as the general population despite exposure to spaceﬂight.20–23
In the military, like the general population, the most frequent cause of
death is CAD, with an increasing trend seen with increasing age.24–26
Whilst recruiting at a younger age, a focus on physical ﬁtness,27,28
reduced obesity levels29–31 and the early discharge of those with conditions known to predispose to CVD, such as diabetes,29,31 chronic kidney
disease or rheumatoid arthritis, may reduce the burden of CVD,32,33 a
higher proportion of males recruited from lower socioeconomic groups,
increased rates of smoking31,34–36 and a paradoxical increased rate of
cardiovascular events due to vigorous exertion may not only negate any
beneﬁts, but worsen cardiovascular health in comparison to the
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for aeromedical disposition considerations. However, due to the limited
sensitivity of the exercise ECG (60–70%),55 an unacceptably high number of individuals with angiographically demonstrable obstructive CAD,
will be deemed normal following a false negative test. Exercise ECG will
also not identify widespread but non-obstructive CAD. Additionally, the
exercise ECG has a very low positive predictive value for future coronary
events. For this reason, the Exercise ECG should be discouraged as a
stand-alone tool to determine signiﬁcant CAD in those who undertake
safety sensitive employment.56

Most CVD studies of the police in the US were undertaken prior to
1990 and thus less relevant to current understandings of SCD among
safety sensitive workers.49,50 One study of 312 male and female police
ofﬁcers, compared to age-matched general population free of clinical
CVD51 demonstrated that police ofﬁcers had elevated levels of
age-adjusted CVD risk factors (blood pressure, total cholesterol, smoking
prevalence) compared with the population sample.
4.3. The safety-sensitive occupational workforce

4.4.3. Other non-invasive functional tests
All functional tests have a speciﬁcity and sensitivity, to determine
obstructive CAD, of approximately 80% at best, and using Bayesian
theory and understanding the prevalence of obstructive CAD in the safety
sensitive workforce, a positive functional test will often more likely be a
false positive than to reﬂect an obstructive coronary lesion. As with the
exercise ECG, functional tests will also not identify widespread but nonobstructive CAD, that may well be occupationally important and confer a
MACE event risk above the acceptable1–2% level required in many safety
sensitive roles. False positive tests also potentially lead to further (unnecessary) investigations that may be associated with procedural risks
from radiation exposure, intervention or the identiﬁcation of additional
incidental ﬁndings that require extensive further investigation. In safety
sensitive workers, this may result in removal from work duty and delays
in appropriate return with related impact on operational effectiveness
and subsequent cost ramiﬁcations to both the worker and employee.

Military personnel, many emergency service personnel, and aircrew
are usually signiﬁcantly younger than the population normally associated
with coronary or cardiovascular health concerns. This is an important
factor when considering applying the published clinical literature on
both diseases, and the effectiveness of investigations in detecting pathology, to this different cohort. The use of Bayesian theory is therefore
important when considering the occupational population and when
applying an evidence base that is based on older individuals who have a
substantially higher disease prevalence. It would be expected that many
individuals undertaking safety sensitive occupations would fall outside
the usual “evidence-base” for decisions made in usual clinical practice.
4.4. Strengths and limitations of existing tests to screen for/investigate CAD
Given the low level of risk that many employers, or regulatory authorities, strive to, careful consideration must be given to whether
screening investigations have enough sensitivity to exclude disease
associated with a risk of just 1–2%. Additionally, the speciﬁcity of a test is
also critical given the need to not exclude workers from employment
unnecessarily whilst ensuring employers are not being falsely reassured
or carrying undeclared risk in excess of that which is acceptable or
mandated by the regulations.

4.4.4. Coronary artery calcium (CAC) score
CAC Scoring is a proven independent CAD risk marker, providing
improved patient-speciﬁc diagnostic and prognostic accuracy over
traditional CAD risk factors alone.57–59 Reporting of CAC has become
standardized in clinical practice utilizing the Agatston method60,61 with
increasing CAC scores associated with a higher incidence of
MACE.10,53,57,62
In the general population CACS provides valuable, patient-speciﬁc
prognostic data and adds incrementally to a patient-centered discussion
of initiation of primary prevention medical therapy.5 A zero CACS is
associated with very low CHD event rates (0.1%/year) and thus identiﬁes
a population of patients in which medical therapies may be
deferred.59,63–66 Conversely, a CACS >100 identiﬁes a high-risk cohort
which, regardless of calculated 10-year ASCVD risk, may beneﬁt from the
initiation of statin therapy.59,66–68 In addition to identifying patients who
are likely to beneﬁt from primary prevention therapies, CACS may also
identify asymptomatic patients with silent ischemia as it has been reported that in patients with extremely high CACS (400), ischemia is
present in up to 50% of patients.69,70
As a risk marker, independent of traditional cardiovascular risk factors, CAC allows for the reclassiﬁcation patients. However, in younger
(<45 years of age), potentially ﬁtter, individuals being screened or
investigated for CAD a normal CACS may not identify occupational
relevant non-calciﬁed CAD, that may have an event risk that is in excess
of the employer’s regulatory limits.119

4.4.1. Risk scores
Traditional risk scores are widely available and, by highlighting CVD
risk factors, are usually ﬁrst line tools. Unfortunately, risk scores have
known limitations in their ability to risk-stratify patients. Evaluation
often rely on history, physical exam, and resting electrocardiogram
(ECG) alone. History may be unreliable considering potential reporting
bias,15,52,53 and rest ECG have poor accuracy in detecting ischemic heart
disease (54).
In aircrew, current methods employed to screen for high-risk aviators
suffer from reduced sensitivity and speciﬁcity, regardless of age group or
pre-test risk of obstructive CAD14,52,54 whilst the application of a Framingham risk model to pilots with a JAA Class 1 certiﬁcate in the U.K.,
demonstrated that 9% of pilots had an estimated 10-year CVD risk
>20%.54
So, whilst many agree that the routine evaluation of pilots and other
safety-sensitive workers is needed to screen for CVD, debate remains
regarding the appropriate use of tests and the most appropriate test to
detect CVD. The chosen test needs to accurately determine whether an
individual has occupationally relevant disease and usually this requires
the accurate identiﬁcation of atheroma more than the identiﬁcation of
obstructive CAD (although the latter is clearly important also).

4.4.5. Coronary CT angiography (coronary CTA)
Coronary CTA is a non-invasive tool that provides high-resolution
imaging of coronary artery anatomy, CAD distribution, and severity
comparable to invasive coronary angiography (ICA).71–73 Coronary CTA
is well-validated in symptomatic patients with low to intermediate pretest risk for obstructive CAD.74,75 Currently, coronary CTA is recommended as the initial test for diagnosing CAD in patients where
obstructive CAD cannot be excluded by clinical assessment60 and in
stable symptomatic patients.76 Coronary CTA also can assess plaque
morphology and high-risk coronary CTA features should lead to an
escalation of medical therapy.11,77–79 This ability to thoroughly evaluate
non-obstructive plaque for both high-risk characteristics and burden is
vital to preventing future CV events.4,5,77

4.4.2. Exercise ECG
Many agencies that employ safety-sensitive workers utilize exercise
stress electrocardiography (exercise ECG) as a ﬁrst line test in individuals
deemed to be at increased risk of cardiovascular disease. This is in a large
part because exercise ECG is widely available, relatively inexpensive, and
does provide useful prognostic information. The exercise ECG has limitations as a screening tool for obstructive CAD due to its limited sensitivity and speciﬁcity. However, it does provide useful risk stratiﬁcation
information, such as BP response to exercise, identiﬁcation of exercise
related arrhythmias, and aerobic ﬁtness. In low-prevalence populations,
a good level of aerobic ﬁtness has signiﬁcant negative predictive value
294
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medical condition. This concept was developed at the ﬁrst UK Workshop
in Aviation Cardiology95 at which time, the all-cause accident rate for
commercial airlines was approximately 0.2 per million ﬂying hours. For
assessing medical risk, the Workshop decided upon a target of 0.1 fatal
accidents per one million ﬂying hours (one in 107 ﬂying hours). Further,
it was argued that aircrew, as part of the overall aircraft system, should
not contribute more than 10% to the total risk. Based on these assumptions, it was argued that medical incapacitation should result in a fatal
accident no more often than one in 1000 million ﬂying hours (1 in 109)
(for details see text box). While this approach has been used for decades,
the 1% rule has some limitations96–98 and the concept of acceptable risk
in commercial aviation remains debatable, with proposed risk limits
ranging from 0.5 to 2% per year.97,99,100 Additional requirements for
older pilots have attracted additional controversy89 since studies
demonstrate an age-dependent risk of pilot incapacitation, although the
value of experience is a signiﬁcant factor in reducing accident risk.99,101
In 2006, ICAO mandated the requirement for a co-pilot under age 60 to
minimize the risk of single-pilot incapacitation in commercial ﬂying.101
Using a set of assumptions pertaining primarily to commercial civil
aviation operations including average duration of ﬂights (1 hour), critical
phases of ﬂight (limited to landing and take-off, representing 10% of
ﬂight time i.e. 6 minutes), and the presence of a co-pilot able to take over
in the case of sudden incapacitation (which reduces risk by a factor of
100), it was calculated that only one pilot incapacitation in 1000 would
be likely to lead to a fatal accident. For a target accident rate of 1 in 10
9
hours, if only 1 in 1000 incapacitations is likely to lead to an accident,
the acceptable medical incapacitation rate is 1 in 106 hours. Since there
are 8760 hours in a year, (~104), the acceptable annual medical event
rate to meet this target is 1% per year. (104  102 ¼ 106). Reproduced
with permission from Grey G, Rienks R, Davenport ED, Guettler N,
Manen O, Syburra T, D’Arcy JL, Bron D, Nicol E D. Assessing Aeromedical
Risk: A three-dimensional risk matrix approach. Heart 2019. Jan; 105
(Suppl 1): s9-16.
It is estimated that 6 pilots from 1965 to 1981 of regularly scheduled
commercial airliners died suddenly from coronary disease while in the
air and the copilot was able to land the plane safely, and the passengers
were not harmed.102 The FAA reports that from 1994 to 2007 only 5
pilots (under the age of 60 years) died whilst in control of commercial
aircraft (103). This is mirrored globally with similar safety records
among older commercial pilots in Japan, with no accidents over a
decade, in pilots aged 60–63 years, compared to 323 total accidents and
27 air-transport accidents in younger pilots (age< 60).90 Most
CVD-related accidents occur in general/private aviators where the
acceptable medical risk is signiﬁcantly greater than for commercial
pilots.88,89

However, in an occupational health setting, most patients are
asymptomatic at presentation and are referred for further assessment due
to a raised cardiovascular risk or abnormal ﬁndings (such as on the ECG).
The predominance of published data for coronary CTA in asymptomatic
patients is in diabetics and high-global CHD risk patients58,80,81 and this
population is unlikely to be representative of the occupational cohort. A
normal cardiac CT provides long term prognostication, as a normal coronary CTA (no plaque and zero CACS) confers a CV event rate of <1%
over in 7 years of follow-up among symptomatic patients.10,82,83 This
level of diagnostic precision and accuracy may permit less frequent
testing and cost savings given, in many instances, annual screening for
raised CHD risk is undertaken.
Despite the clinical utility of both CACS and coronary CTA in
asymptomatic patients, there remains a lack of guidance on the utilization of these modalities in the screening of certain high-risk occupational
health populations. The use of either CACS or coronary CTA should not
be applied indiscriminately to all individuals who may be employed in
safety sensitive ﬁelds, but used if initial screening identiﬁes a potential
increased likelihood of occupationally signiﬁcant cardiovascular disease,
or if the level of risk acceptance is such that clear and unequivocal
exclusion of occupationally relevant CVD is required.
4.4.6. Invasive coronary angiography
The routine use of invasive coronary angiography (ICA) is problematic in asymptomatic safety sensitive workers for several reasons. This is
because ICA is associated with a risk of stroke, MI, coronary dissection
and vascular access damage in as many as 1 in 30 cases.84 The overall risk
of death with ICA is approximately 1 in 1000. ICA is preferably undertaken based on clinical indications for individuals likely to require
intervention. Its use for an occupational indication requires detailed
discussion and appropriate consent from the patient concerning risks and
beneﬁts, given the possible career implications of a procedure-related
event.
5. Speciﬁc safety sensitive occupations
This section reviews the evidence for cardiovascular investigation as
well as investigations to screen for occupationally relevant CAD for
speciﬁc safety sensitive occupations and the current occupational
standpoints with regards the effect of CVD on these professions.
5.1. Commercial pilots
With an estimated rate of nearly 0.1 fatalities per million ﬂights,
aircraft loss attributed to cardiovascular disease (CVD) in pilots is rare.82
Similarly, pilot incapacitation in-ﬂight is uncommon, with a reported
incidence of 0.1–0.8 per million ﬂight hours.15,85 However, exceptions
do exist where pilot incapacitation results in aircraft accidents and fatalities.82,86,87 As a result of these rare events, screening for CVD and its
risk factors remain essential components of licensing requirements to
ensure air safety.88–90
The International Civil Aviation Organization (ICAO) sets the minimum standards for pilot licensure91–93 but additionally, individual
agencies guide commercial pilot licensure, including the Federal Aviation Authority (FAA) in the United States, the European Aviation Safety
Agency (EASA) in Europe and the Civil Aviation Authority (CAA) in the
UK. Despite efforts to unify standards, diverse approaches exist to evaluate a pilot’s risk for CVD events with variable requirements to report
medical conditions to authorities, although efforts have recently been
undertaken to improve consensus in cardiovascular risk assessment by a
group of aviation cardiologists working as part of a NATO initiative to
develop international consensus in this ﬁeld.94
When considering occupational limitations in aircrew, the usual
acceptable risk of incapacitation for multi-pilot commercial ﬂying is
based on the so-called “1% rule.” This rule states the maximum acceptable risk of pilot incapacitation should be less than 1% per year from any

5.1.1. Cardiac investigation for CAD in commercial pilots and aircrew
Most pilots with subclinical CAD will never manifest during their
careers, and yet latent CAD remains a prevalent ﬁnding in aircrew. Autopsy data has revealed that moderate-to-severe coronary artery stenosis
is seen in up to 5–20% of pilots, with an age-dependent increase in
prevalence.104–107 Consequently, ICAO does not require routine exercise
ECG, whilst multiple guidelines have provided variable recommendations for screening with an exercise ECG in pilots.
5.2. Military pilots and aircrew
Military air operations often are performed by pilots and aircrew
operating high performance aircraft that require their full engagement
throughout the mission. While acute incapacitation among military pilots
is rare, in the United States Airforce (USAF) cardiac events are a leading
cause of in-ﬂight incapacitation.108–110 Autopsy studies among military
pilots and aircrew reveal that atherosclerotic cardiovascular disease is a
common ﬁnding, and in some cases, there is evidence of severe disease.18,111 Furthermore, there is evidence of systemic underreporting of
cardiac symptoms among the military pilot and aircrew population112
295
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likely stemming from aircrew being cognizant that CV disease is the most
common reason for ﬂight disqualiﬁcation.56,112–114

5.4. Military personnel
Military personnel are recruited from their parent nation and allies
but are not often reﬂective of the wider population. Many aspects of
military service, such as the primacy of mission success and training for
that purpose, are generalizable. However, recruitment policies and
differing health economies coupled with cultural and racial131–133 variances may impact on background levels of cardiovascular disease
(CVD).134,135
As in the general population, age is an important determinant for CVD
in the military,124–126 with the incidence of death in the US military
secondary to CAD for those <35 years of age being 0.65 per 100 000
service years, 13.69 in those >35 years of age, and 83.5 in those >50
years.136 Overall annual rates of ischemic heart disease (IHD) having
decreased from 0.80 per 1000 person years to 0.68 per 1000 person
years) over the past decade136 but may now be again on the increase.118
In the UK Armed Forces over a 16-year period from 1995 to 2011, the
overall mortality rate from CVD, was 7.81 per 100 000 service years, with
CAD being the most common cause of sudden cardiac death (SCD)26 and
the most frequent cause of cardiovascular medical discharge from service.26 A retrospective review of 126 atraumatic deaths of 6.3 million
military recruits aged 18–35 years of age demonstrated that coronary
artery abnormalities, including anomalous coronary origins, were the
predominant structural cardiac abnormality (61%).137

5.2.1. Cardiac investigation for CAD in military pilots and aircrew
Prior to the utilization of CACS, the absence of coronary artery calciﬁcations by ﬂuoroscopy demonstrated a high negative predictable
value for signiﬁcant coronary artery disease among asymptomatic military aircrew.115
Historically, functional assessment, both with and without myocardial perfusion scintigraphy (MPS), among USAF pilots and aircrew has
been a poor predictor of future cardiovascular events, with MPS
demonstrating a poor sensitivity and speciﬁcity. Over 20 years similar
cardiac event rates occurred in those with normal or abnormal functional
assessment tests.56 Among USAF pilots with an abnormal functional
assessment, 62% had no evidence of coronary artery disease while 12%
had evidence of obstructive CAD.56
Pilots and aircrew with CACS of 10–99 have a predicted annual cardiac event risk of 0.5%, while those with CACS of >100 had a >1%
annual risk of major adverse cardiac events (MACE).52,116,117 This
correlated to ICA data on USAF pilots, where luminal irregularity had an
annual event rate of 0.5%, an aggregate stenosis of up to 50%, a 1% event
rate and the presence of a stenosis of >50% was associated with annual
MACE event rate of 2.2%.118 In comparison the presence of more than
one 50% stenosis, a single stenosis >70%, or a >50% stenosis in the left
mainstem were all associated with a >3% annual MACE event rate.119
While there is currently no outcome data for coronary CTA in aircrew,
a recent publication on UK military aircrew demonstrated that coronary
CTA was able to detect clinically and aeromedically signiﬁcant CAD,
even in those with a CACS of zero, and argued that coronary CTA could
be the investigation of choice in those deemed high risk of occupationally
relevant CAD.120

5.4.1 cardiac investigation for CAD in asymptomatic military personnel
Notably, 2.3% of US military service personnel who died of combat,
or unintentional injury, during recent operational deployments, to Iraq
and Afghanistan, had severe coronary atherosclerosis.138 As previously
described exercise ECG is still often used as a ﬁrst line test in individuals
deemed to be at increased risk of cardiovascular disease, although this is
increasingly recognized as being suboptimal for the detection of occupationally relevant CAD.139 The US military often uses CACS to risk
modify individuals with a 10-year atherosclerotic CVD risk of 5–20% as
directed by the ACC/AHA guidelines140,141 Coronary artery calcium
scoring (CACS) has been established in both the U.S. and Canadian
military as a validated screening tool for the assessment of CAD in
aircrew.120
The use of cardiac CT for the screening of asymptomatic service
personnel is not used for either the US or UK Armed Forces given the
limited evidence for its use in asymptomatic individuals in the general
population.142 In the UK Armed Forces, safety sensitive groups such as
divers and aircrew are ‘screened’ with periodic ECG, with a low threshold
for further evaluation if abnormalities suggestive of CAD are
found.143,144 This may include cardiac imaging following comprehensive
clinical assessment.142–145 In the UK and Germany coronary CTA is
preferred to CACS due to the ability to assess for non-calciﬁed and
vulnerable plaques, anomalous coronary origins and the higher negative
predictive value of CCTA that additionally reduces subsequent downstream testing.120,142

5.3. Astronauts
Maintenance of cardiovascular health among astronauts is important
given the recognized cardiovascular adaptations associated with spaceﬂight.94–99,115,121–125 To date, there is contradictory evidence associating
these physiological effects to an increased lifetime risk for cardiovascular
disease (CVD).126–128 In the past researchers have suggested that astronauts have a 3–5% risk of developing CVD by their ﬁfth decade of life128
but the absolute risk of all-cause mortality during space ﬂight is unknown. All deaths during space ﬂight have been related to catastrophic
failure of critical life support systems or the transport vehicle.
5.3.1. Cardiac investigation for CAD in astronauts
Current National Aeronautics and Space Administration (NASA)
guidelines, established with the assistance of a committee of national
experts, use a criterion of coronary artery calcium score (CAC) to exclude
astronauts from the corps.127–129 High performance aircraft personnel
must be examined by a certiﬁed NASA Flight Surgeon or Aviation Medical Examiner and screened for anomalies and conditions that could pose
a health or safety threat to the individual or mission.129 Cardiovascular
status is assessed using standardized cardiovascular risk assessment tools,
including the Framingham Risk Score and the Reynolds Score. If the
calculated 10-year risk for an adverse cardiovascular event is  10%,
evaluation by a cardiologist is required and any conﬁrmed cardiovascular
disease is disqualifying.129 Recently the Astronaut Cardiovascular Health
and Risk Modiﬁcation (Astro-CHARM) tool was developed and validated
to enhance cardiovascular risk prediction among astronauts and the
general population.130 A patients’ 10-year risk of ACVD is determined
through an integration of risk factors (including family history of early
MI and high sensitivity C-Reactive Protein (Hs-CRP) in combination with
CACS and was developed across 3 large population cohorts. In a large
population cohort, it was validated and found to improve CV risk prediction when compared to traditional risk factors.130

5.4.2. Cardiac investigation for CAD in symptomatic military personnel
Military personnel presenting with symptoms of IHD require expeditious evaluation. The US military have forward deployed cardiologists
in recent conﬂicts146,147 due to cardiovascular complaints being a common reason for aeromedical evacuation with chest pain being a common
complaint.148 Over 80% of military personnel presenting with cardiovascular symptoms during recent conﬂicts are returned to the front-line,
with operational presentations of ACS being relatively uncommon,24,149
albeit resource intensive.146,148 Death from CVD on operational deployment is declining (4.1 per 100,000 person-years in the US military)
although more prevalent in the reserve component.150
Societal guidelines, which favor a probability-based approach to the
investigation of stable CAD, arguably do not provide acceptable levels of
diagnostic certainty to allow for adequate risk assessment for military
patients due to the low prevalence of CAD.142,151,152 The principle test
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(IR 11.0 per 100 000 person-years, 95% CI 8.9 to 13.7) compared with
high-risk duties (IR 38.3 per 100 000 person-years, 95% CI 31.5 to
46.6).37

requirements for military personnel are a high sensitivity and negative
predictive value. Coronary CTA has been studied in the military population, demonstrating its accuracy in ruling out occupationally signiﬁcant
CAD,153 identifying anomalous coronary artery origins,154 and informing
cardiovascular prognosis.155 Coronary CTA also demonstrated lower
rates of subsequent evaluations for chest pain and repeat testing,156 and
an increase in the use of preventive cardiovascular medications,157 whilst
reducing the radiation exposure to service personnel.158 A recent
meta-analysis demonstrated a CCTA can exclude anatomically deﬁned
coronary artery disease in nearly all patients regardless of their pre-test
probability.159 Service personnel without evidence of coronary atherosclerosis have an excellent prognosis over mean follow of 24 months155
aligning with 10-year event free survivals against cardiac death and
non-fatal myocardial infarction.78 This assurance reduces scheduled and
unscheduled re-evaluations for in those with a history of chest pain79
and is now the cornerstone of the UK Armed Forces approach, that also
reﬂects existing reﬂecting NICE guidance for those with stable chest
pain60.
In the US military, single photon emission tomography (SPECT) remains the most frequently performed imaging modality for risk stratiﬁcation although with a demonstrated false positive rate of nearly 15%
and nearly 93% those referred for ICA having no evidence of obstructive
CAD.160 In contrast, CCTA effectively rules out obstructive CAD in 98% of
patients with 16.5% having non-obstructive coronary atherosclerosis,
with an incident of referral to invasive coronary angiography required in
just 2.4%.153
In the military, a deployed CT scanning capability has proven
invaluable for the management of trauma in recent conﬂicts.161 One
interesting example was a non-gated cardiopulmonary CT performed for
acute chest pain and shock in the operational environment that
conﬁrmed both situs inversus totalis and an acute mid-LAD thrombus in
an Indian military contractor, who was immediately treated with
thrombolysis and transferred for secondary coronary intervention.162

5.5.1. Cardiac investigation for CAD in asymptomatic ﬁreﬁghters
Much work has been done exploring sub-clinical atherosclerosis
among active duty ﬁreﬁghters in the US. CACS and carotid intimal
thickness (CIMT) have both been extensively investigated and shown to
be useful for identifying increased risk and in subsequently implementing
primary prevention.169 In one study of 495 ﬁreﬁghters, 131 (26.9%) had
positive CACS and underwent CT coronary angiography; 40 (8.1%) had
>50% stenosis on coronary CTA and underwent subsequent ICA.169 In a
further study of 296 professional ﬁreﬁghters, assessing CVD risk with
CACS and CIMT, linear regression demonstrated homeostasis model
assessment (HOMA) as the strongest predictor of increased CIMT, raised
fasting glucose was the strongest predictor of total coronary lesion
number and score, and insulin resistance was shown to be directly
correlated to CVD.170 In a study of 399 asymptomatic ﬁreﬁghters
increased CACS was found only in men >34 years of age. Of the 53% who
had an Agatston score >0, 87% had higher CACS compared with age
matched subjects in a national database,171 a ﬁnding mirrored in a study
of 647 asymptomatic ﬁreﬁghters, where employment as an active duty
ﬁreﬁghter was independently associated with a 41-point increase in the
age-matched CACS.172
5.6. Police ofﬁcers
Police ofﬁcers are known to have higher mortality rates than the
general population secondary to suicide, increased rates of cancer and
cardiovascular disease (CVD).49,50,173–176
As compared to ﬁreﬁghters, relatively little research has been performed into understanding the increase in ASCVD among police, with
only two small longitudinal studies having been reported. In one study,
220 male police ofﬁcers demonstrated no statistically signiﬁcant difference in the IR of coronary heart disease at 10-year follow-up when
compared to a general population cohort.174 A second study of 232 male
retirees from the Iowa Department of Public Safety reported a statistically
signiﬁcant increase in the incidence of self-reported cardiovascular disease when compared with controls.173

5.5. Fireﬁghters
The risks of both burns and smoke inhalation are well understood in
ﬁreﬁghters.163 However, less appreciated is that the most frequent cause
of death among ﬁreﬁghters is heart disease. Cardiovascular events, speciﬁcally MI and SCD account for 45% of deaths among ﬁreﬁghters on
active duty.163,164 In contrast, such events account for 22% of deaths
among police ofﬁcers on duty, and 11% of deaths among emergency
medical services workers.16,48,164
Fireﬁghters are generally regarded as a selected group of healthy
workers. By the nature of their high levels of ﬁtness and health, they are
expected to show a lower risk of cardiac events compared with the
general population (“healthy worker effect”).16,17 The healthy worker
effect is determined by both the initial selection process (hiring more ﬁt
persons) and the continuing employment of healthy persons, who typically get annual physicals to assess levels of ﬁtness and ﬁtness for duty.17
The US Fire Administration (USFA) collects data on all on duty ﬁreﬁghter fatalities occurring in the United States, and reliable measures of
the number of US career ﬁreﬁghters are available from the Current
Population Survey (CPS).165,166 In addition, the National Institute for
Occupational Safety and Health (NIOSH) performs independent investigations of ﬁreﬁghter line-of-duty deaths.167 In a 14-year study of
>300 000 US full-time male career ﬁreﬁghters, aged between 18 and 64
years, the rates of SCD were similar to the US male general population
and military personnel similar among younger persons, but diverged
after the age of 45 years. After 45 years, the rates were 30–56% lower
among ﬁreﬁghters than age-matched groups in the military and this was
felt to be because less ﬁt persons would retire from ﬁreﬁghting, thereby
reducing the population at-risk. The pattern of SCD observed in ﬁreﬁghters is similar to sports related SCD in the general population,
although ﬁreﬁghters experience higher rates of SCD compared with
athletes.168 The incidence rates (IR) of SCD was lower for low-risk duties

5.6.1. Cardiac investigation for CAD in asymptomatic police ofﬁcers
In one study police ofﬁcers exhibit increased CIMT and increased
levels of atherosclerosis compared with a general population sample, not
completely explained by elevated CVD risk factors whilst a second study
of 2064 New York City police demonstrated a positive CACS in 74% of
men and 80% of women but no increase in the prevalence of CAD
compared with the general population.51
5.7. Commercial drivers
Of the estimated 3.5 million US drivers that have a commercial
driver’s license, nearly all Commercial Motor Vehicle (CMV) license
holders are required to meet federal medical standards as a condition of
employment.177,178 Evaluation and treatment of coronary heart disease
(CHD) is intended to reduce the probability of sudden death during
commercial driving that can result in harm to the general public and the
drivers themselves.
The National Health and Nutrition Examination Survey (NHANES
2001–2012) reported that 8–10% of those over 40 years of age have CHD
(deﬁned as having prior heart attack, angina, or diagnosis of congestive
heart failure) that can predispose to sudden death events.179 Among
those who died from sudden death, the most likely etiology was ischemic
coronary heart disease. Prolonged sedentary habits, infrequent structured physical activity and erratic shift-work hours and sleep schedules
can lead to additional CHD risk. In addition to traditional CHD risk factors, prolonged performance of vigilant tasks to avoid adverse
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commercial driver’s license does not restrict work activity, drivers need
to be able to display the ability to perform reasonable exertion in order to
be certiﬁed.203 Treadmill or other cardiac stress testing evaluated the
driver’s ability to work at a speciﬁed level of exertion prior to returning
to work without cardiac symptoms or evidence of ischemia or
arrhythmia. The ability to increase exercise capacity [measured by
metabolic equivalent term (MET) on the exercise test] in both employees
with a history of MI and healthy individuals correlated with decreased
cardiovascular disease and all-cause mortality compared to those with
less robust exercise tolerance.204 Completion of Stage II (>6 METS) of the
standard Bruce treadmill protocol, equivalent to lifting heavy objects of
50 lbs or more, is considered sufﬁcient for a commercial driver to
perform job-related tasks.205 There are little data on patients returning
after an aborted SCD although in one study, of thirty-ﬁve (70%) individuals that returned to commercial driving after a SCD event, 5
probably had a second SCD, with 2 of 5 found dead at the side of the road
in their trucks, 2 at service stations, and 1 while working a non-driving
job.197

consequences, such as long-haul driving, has been associated with hypertension and CHD in humans.180,181 Although commercial driving involves variable degrees of physical activity, it mostly comprises
sedentary driving where the likelihood of activity-related sudden death
event is lowest.182 However, drivers may have to exert themselves such
as when changing a tire on the vehicle, securing the load, or loading or
unloading cargo which will place them at higher risk of SCD during or
soon after exertion.183–185
Commercial drivers face also additional stressors, including the need
to adhere to tight schedules, long hours in a seated position, trafﬁc
congestion, poor social support, and the need to maintain courtesy
despite belligerent passengers.40,42,186,187 Increased stress has been
shown to lead to catecholamine and cortisol release that increases arterial tone, myocardial excitability and contractility, and stimulates
thrombus formation.186 Environmental exposures such as excessive
noise, temperature extremes, air pollution, whole body vibration, and
oncoming glare routinely encountered by commercial drivers may also
have detrimental effects on cardiovascular health.38,181,188,189
In several studies of sudden incapacity for drivers in any vehicle,
arrhythmia was the most common cause although the prevalence ranged
widely from 21% to 100% of cases.117,190,191 Interestingly, early studies
reported drivers who suffered arrhythmias or died suddenly on the job
did not cause serious harm to the general public.192–194 Most of the
drivers were able to stop their vehicles without injury.195 One of the
potential reasons for relatively low incidence of crashes from arrhythmia
or SCD is due to the length of time between the onset of the cardiovascular event and incapacitation. A typical motor vehicle crash can occur in
5 s or less. However, prior to an accident, the time required for a driver to
recognize illness and slow down or stop the vehicle may take up to ﬁve to
10 seconds.196 The arrhythmic abnormalities leading to incapacity requires a time of onset, during which blood ﬂow to the brain is partially
maintained allowing the driver to become aware that something is wrong
and have time to react. In many instances, drivers can quickly identify
that they are ill and have time to pull to the side of the road.182,196 An
early study of commercial drivers, 50 proven myocardial infarctions, 12
(24%) occurred during scheduled work hours but no vehicle crashes
resulted.197 More recent reports show that 20–50% of drivers experiencing a SCD stopped their vehicles with minimal injury to themselves or
others.192–195,198 One of the studies found 1/3 of drivers were able to
stop the vehicle before becoming unconscious with only 6% of other
people at risk in the car accident suffering minor injuries.193 Subsequent
investigations suggest that accidents in commercial vehicles can be as
high as 80%198 although mortality of either occupants of the vehicles or
other drivers is rare.

6. Summary
A review of the current occupational guidelines suggests that many
organizations still rely on traditional CHD risk evaluation with or without
the use of cardiac stress testing (whether exercise ECG or functional
imaging). This approach runs the risk of missing important occupational
CAD. The literature review performed has identiﬁed that a cardiac CT
based approach to determining occupational cardiovascular risk can be
valuable mainly due to the unparalleled negative predictive value a of
coronary CTA. For risk assessment in individuals undertaking safety
sensitive work, both CACS and coronary CTA can evaluate an employee’s
risk for CVD events with a high degree of accuracy. Whether CACS or
coronary CTA is performed is most likely determined by the level of risk
accepted by an employer and the importance of determining noncalciﬁed CAD as part of any occupational assessment. In most cases,
the presence of mild CAD alone should not trigger untoward restrictions,
even in pilots with no symptoms. Instead, the identiﬁcation of subclinical
CAD should serve as an opportunity to control modiﬁable ASCVD risk
factors.
In summary, the decision to pursue a test for occupational screening
must weigh individual considerations against the duty to protect society
at large, considering various occupational hazards and access to medical
care. ‘First do no harm’ applies both to the patient and the population atrisk. All studies identiﬁed in the literature review demonstrated an increase in identiﬁed atherosclerosis burden correlated closely with an
increased risk of SCD, therefore screening of a safety sensitive workforce
seems prudent, given the increased risk of CVD and SCD, and the ample
treatments (lifestyle and pharmacologic) available to mitigate the effect
of disease in those at risk (Figs. 3 and 4).

5.7.1. Cardiac investigation for CAD in asymptomatic commercial drivers
CHD risk screening of commercial drivers is recommended using
validated risk scores, such as the Framingham risk score199 or the
atherosclerotic cardiovascular disease (ASCVD) score (63) to initiate
aggressive risk factor management or additional cardiac testing However, additional cardiac stress testing is more controversial and other
testing, such as CACS, has not been reported in this population.200,201
The United States Preventive Services Task Force (USPSTF) concluded
that screening asymptomatic individuals in certain high-risk occupations,
such as commercial drivers, could be recommended based on the possible
beneﬁt to public safety.178,202 However, the USPSTF cited insufﬁcient
evidence to recommend for or against routine cardiac stress testing of
asymptomatic commercial drivers with CHD risk factors.202 The American College of Cardiology and American Heart Association Guidelines
for Exercise Testing203 similarly noted that there are insufﬁcient data to
justify routine treadmill stress testing although “evaluations are done for
statutory reasons”5 in some cases.

7. Limitations
We recognize several limitations in our consensus document and
available evidence. While we aimed to provide a comprehensive review
of the literature, potential exists for missing data and publication bias. To
minimize this, we reviewed multiple databases including grey literature
and a recursive search of references. Our consensus document provides a
review of risk assessment in various safety-sensitive occupations but is
not all-inclusive of occupations that may warrant evaluation for CVD and
its risk factors. We recognize that different risk applies to different professions and impact on safety to the general public, an example will be
the presence of co-pilot in commercial ﬂights and the absence of one in
military ﬂights, or the duration of the mission and distance for astronauts
that does not apply to other professions. However, the authors attempted
to provide a comprehensive “enhanced screening” for all these professions with as little variance possible as long as they remain active in
their profession. It is not the intention of the authors, to advocate

5.7.2. Evaluation of drivers with known CHD or prior aborted SCD
Advances in the treatment and management of CHD allow commercial drivers with known disease to return to the workforce. While the
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Fig. 3. Role of calcium score in occupational health assessment.

Fig. 4. Role of coronary CT in occupational health assessment.

conduction disorders, arrhythmias, and adverse effects of medications.
As with existing guidelines, our consensus document is subject to
author and responder bias. To minimize this, we incorporated a broad
review of evidence with feedback from multiple specialties. While our
consensus document provides guidance for the use of CAC testing and
coronary CTA, the need for any cardiac testing remains at the discretion
of occupation health providers and their regulation agencies. Variations
in individual presentations are expected, and deviations from this
consensus document may occur. Consequently, open communication is
encouraged among providers, employers and patients to clarify any

enhanced screening to be applicable to the general population in
contradiction to current national or international guidelines but rather to
address the need for enhanced screening in those with high-risk occupations. Attention was given to primary ASCVD risk assessment in patients without known cardiovascular disease. Secondary risk assessment
in occupation candidates with a history of known obstructive CAD, prior
myocardial infarction or revascularization was not considered, as the role
of CAC and CTA is more limited in these patients. Beyond the scope of
this consensus document, adverse cardiac events may result from structural heart disease, physiologic responses to occupation environments,
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testing requirements. Lastly, the precise role for health screening in
occupation exams remains an ongoing debate, and collaboration is
needed among interest groups to provide transparent criteria for occupational exams that balance individual health, patient rights and public
safety.
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